Medical Insights

Breast Cancer Presentation, Treatment Patterns, and Progression-Free Survival at a Tertiary Oncology Centre in Bangladesh: A Retrospective Study

D

Dr. Md. Arifur Rahman

Oncology Specialist

Breast Cancer Presentation, Treatment Patterns, and Progression-Free Survival at a Tertiary Oncology Centre in Bangladesh: A Retrospective Study

Real-World Breast Cancer Evidence from Bangladesh is Now Published! I'm delighted to share that our long waited study has now been published in Cancer Reports (Wiley). "Breast Cancer Presentation, Treatment Patterns, and Progression-Free Survival at a Tertiary Oncology Centre in Bangladesh: A Retrospective Study" This work analyzes 1,058 consecutive breast cancer patients, making it one of the largest published real-world institutional breast cancer datasets from Bangladesh to date. Why this study matters Breast cancer outcomes from South Asia are still underrepresented in the global literature. Our study provides contemporary evidence on: • Molecular subtype distribution in Bangladeshi women • Stage at presentation • Treatment patterns in routine clinical practice • Progression-free survival according to molecular subtype • Real-world implementation of multidisciplinary breast cancer care Key findings ✔ Luminal A remained the most common subtype (38.5%) ✔ More than one-third of patients were younger than 50 years ✔ One-third presented with Stage III/IV disease ✔ Chemotherapy remained the commonest treatment modality ✔ Mastectomy was still performed much more frequently than breast-conserving surgery ✔ Luminal B (HER2-negative) and HER2-positive disease demonstrated significantly poorer PFS compared with Luminal A. This publication highlights both the remarkable progress being made in breast cancer care in Bangladesh and the persistent disparities that still require attention. Most importantly, it demonstrates how real-world data generated locally can guide policy, improve clinical practice, and stimulate future research. I am grateful to all co-authors, our multidisciplinary team, Bangladesh Specialized Hospital, our patients, and everyone who contributed to this work. This is only the beginning. #Bangladesh #BreastCancer #RealWorldEvidence #PrecisionOncology #CancerResearch #GlobalOncology #LMIC #Oncology #CancerReports #BreastCancerResearch #SurvivalAnalysis #ClinicalResearch #BSBCS #bsh #oncoedu